Zenosense, Inc. (OTC Pink: ZENO) is engaged as a medical device manufacturer. Shares of the cardiac diagnostic device maker are rallying 15.52%, through afternoon trading on Friday, May 19, 2017. Over the past month, Zenosense, Inc. has seen average daily volume of 1.13 million shares. However, volume of 86,320 shares or dollar volume of $57,834, has already exchanged hands on Friday.

Shares of the Zenosense, Inc. are gaining today, after the company reported first quarter 2017 earnings. During the first three months of the year, the company reported no revenues and a net loss of $132,936. This compares to first quarter 2016 earnings, which came in at no revenue and a net loss of $28,015. Furthermore, the medical company saw total current assets come in at $353,387 and total current liabilities of $295,898. Here is the income statement from the 10-Q:

Zenosense, Inc. 10-Q:

ZENOSENSE, INC.

Statements of Operations

For the Three Months Ended March 31, 2017 and 2016

(Unaudited)

March 31,

2017

March 31,

2016

Revenues $ $
Operating expenses
General and administrative expenses 36,949 26,606
Total operating expenses 36,949 26,606
Loss from operations (36,949 ) (26,606 )
Other income/(expense)
Interest expense (62,328 ) (1,409 )
Loss in equity method investment (33,659 )
Total other expense (95,987 ) (1,409 )
Net loss $ (132,936 ) $ (28,015 )
Net loss per common share:
Basic and diluted $ (0.01 ) $ (0.00 )
Weighted average common shares outstanding:
Basic and diluted 17,673,872 7,087,900

Add a Comment to this Post

comments